Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision v3.4.3 was added to the history and revision v3.4.2 was removed.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new Revision: v3.4.2 to the record history. The government-funding notice and the prior Revision: v3.4.1 entry were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide funding/operating status notice and updated the page revision from v3.4.0 to v3.4.1 (removing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page adds Study Record Versions, Record History, and Results Posted sections and includes sponsor/investigator details and status updates.SummaryDifference52%

- Check62 days agoChange DetectedAdded a new revision entry 'Revision: v3.3.4' to the history and removed the previous 'Revision: v3.3.3'. This change concerns revision history metadata and does not affect study content or functionality.SummaryDifference0.0%

- Check83 days agoChange DetectedFooter policy updates: Revision: v3.3.3 added; HHS Vulnerability Disclosure and Revision: v3.3.2 references removed. These changes are site-wide and do not affect trial data, eligibility criteria, or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.